Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1978 May;75(5):2401-5.
doi: 10.1073/pnas.75.5.2401.

Control of proliferation and differentiation in B lymphocytes by anti-Ig antibodies and a serum-derived cofactor

Control of proliferation and differentiation in B lymphocytes by anti-Ig antibodies and a serum-derived cofactor

C L Sidman et al. Proc Natl Acad Sci U S A. 1978 May.

Abstract

The effects of various anti-Ig antibodies on different B lymphocyte functions were investigated. With the proper accessory cofactor(s) derived from serum, anti-IgM antibodies induced a vigorous proliferative response in normal adult murine B cells, while polyspecific anti-Ig and anti-IgD had no effect. Without the required cofactor, all three anti-Ig antibodies were inhibitory for mitogenic responses. All three anti-Ig antibodies were also inhibitory for mitogen-induced antibody responses with or without the cofactor. Even with the required cofactor, neonatal B cells as well as adult C3H/HeJ B cells were not triggered into proliferation by anti-IgM. Finally, the cofactor required for anti-IgM-triggered mitogenesis was shown to be generated from serum by 2-mercaptoethanol and to be approximately 65,000 in molecular weight. These results indicate that, for at least some responses, B lymphocyte surface IgM molecules are involved in both triggering and suppression, depending both on the developmental state of the B cell and the presence or absence of accessory influences. In these experiments, IgD gave evidence only of being suppressive.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Exp Med. 1965 Aug 1;122:423-40 - PubMed
    1. Immunol Rev. 1977;37:50-88 - PubMed
    1. J Exp Med. 1978 Mar 1;147(3):814-29 - PubMed
    1. J Immunol. 1977 Dec;119(6):2084-8 - PubMed
    1. J Exp Med. 1977 Apr 1;145(4):1029-38 - PubMed

Publication types

LinkOut - more resources